Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Apidra

02 1Others Diabetes

PharmaCompass

01

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2019 Revenue in Millions : 375

2018 Revenue in Millions : 389

Growth (%) : -4

Sanofi Company Banner

02

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 402

2019 Revenue in Millions : 416

Growth (%) : -3

Sanofi Company Banner

03

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2014 Revenue in Millions : 16.70%

2013 Revenue in Millions :

Growth (%) :

Sanofi Company Banner

04

Brand Name : Others Diabetes

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 966

2020 Revenue in Millions : 362

Growth (%) : 164

Sanofi Company Banner

05

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2015 Revenue in Millions : 370

2014 Revenue in Millions : 414

Growth (%) : 12%

Sanofi Company Banner

06

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2016 Revenue in Millions : 389

2015 Revenue in Millions : 399

Growth (%) : -2

Sanofi Company Banner

07

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2017 Revenue in Millions : 467

2016 Revenue in Millions : 455

Growth (%) : 3

Sanofi Company Banner

08

Brand Name : Apidra

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Insulin Glulisine

Main Therapeutic Indication : Diabetes

Currency : USD

2018 Revenue in Millions : 403

2017 Revenue in Millions : 426

Growth (%) : -5%

Sanofi Company Banner